DMT210 Topical Gel in the Treatment of Acne Rosacea
Status:
Completed
Trial end date:
2017-08-30
Target enrollment:
Participant gender:
Summary
The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied
twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of
participants will receive DMT210 Gel while the other half will receive vehicle control.